Related Experiment Video
Updated: Apr 27, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation
Elizabeth Lokich1, Rakesh K Singh2, Alex Han1
11] Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital, Alpert Medical School at Brown University, Providence, RI, 02905, USA [2].
Abstract:
Antiestrogens including tamoxifen and fulvestrant have been evaluated as chemotherapeutics for ovarian cancer, particularly in cases of platinum resistant disease. Human epididymis protein 4 (HE4) is highly overexpressed in women with ovarian cancer and overexpression of HE4 has been found to correlate with platinum resistance. However, the role of HE4 in modulating responses to hormones and hormonal therapy has not been characterized in ovarian cancer. Here we demonstrate that 17β-estradiol, tamoxifen, and fulvestrant induce nuclear and nucleolar translocation of HE4 and that HE4 overexpression induces resistance to antiestrogens. HE4 was found to interact with estrogen receptor-α (ER-α), and HE4 overexpression resulted in ER-α downregulation in vitro and in human ovarian cancers. We identified a novel role for importin-4 in governing the nuclear transport of HE4. Treatment with ivermectin, an importin inhibitor, blocked HE4/importin-4 nuclear accumulation and sensitized HE4-overexpressing ovarian cancer cells to fulvestrant and tamoxifen.
Insights
Human epididymis protein 4 (HE4) drives antiestrogen resistance in ovarian cancer by interacting with estrogen receptor-alpha. Importin inhibitors like ivermectin may overcome this resistance, sensitizing cancer cells to hormonal therapies.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Antiestrogens like tamoxifen and fulvestrant are explored for platinum-resistant ovarian cancer.
- Human epididymis protein 4 (HE4) is overexpressed in ovarian cancer and linked to platinum resistance.
- The role of HE4 in hormonal therapy response in ovarian cancer remains unclear.
Purpose of the Study:
- To investigate the role of HE4 in modulating ovarian cancer response to hormonal therapy.
- To characterize the interaction between HE4, estrogen receptor-alpha (ER-α), and nuclear transport.
- To explore importin inhibition as a strategy to overcome HE4-mediated antiestrogen resistance.
Main Methods:
- Investigated the effect of 17β-estradiol, tamoxifen, and fulvestrant on HE4 localization.
- Assessed the interaction between HE4 and ER-α using in vitro and human ovarian cancer samples.
- Utilized importin inhibitors, specifically ivermectin, to block HE4 nuclear transport.
Main Results:
- 17β-estradiol, tamoxifen, and fulvestrant induced nuclear and nucleolar translocation of HE4.
- HE4 overexpression conferred resistance to antiestrogens and led to ER-α downregulation.
- HE4 interacts with ER-α, and importin-4 mediates HE4 nuclear transport.
- Ivermectin treatment blocked HE4 nuclear accumulation and sensitized HE4-overexpressing cells to antiestrogens.
Conclusions:
- HE4 plays a critical role in mediating resistance to antiestrogen therapy in ovarian cancer.
- Targeting HE4 nuclear import via importin inhibitors represents a potential therapeutic strategy.
- Combined therapy with importin inhibitors and antiestrogens may overcome treatment resistance in ovarian cancer.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Intracellular Hormone Receptors
Regulation of Nuclear Protein Sorting
Nuclear Localization Signals and Import
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Export of Misfolded Proteins out of the ER

